Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 6686

Sort by

Sort Order Select

Journal Articles

Exploiting tumor-derived IL-10 activity in lymphoma therapy

Reuben Tooze, Ulf Klein

Blood (2025) 145 (23): 2676–2678.

https://doi.org/10.1182/blood.2025028445

Published: 2025

Journal Articles

The advent of multiomics in experimental transplantation

Gerard Socie

Blood (2025) 145 (23): 2681–2682.

https://doi.org/10.1182/blood.2024028276

Published: 2025

Journal Articles

Classic Hodgkin lymphoma in the cerebellum: a rare site for a common disease

Yukiko Kitagawa, Elaine S. Jaffe

Blood (2025) 145 (23): 2799.

https://doi.org/10.1182/blood.2025028992

Published: 2025

Journal Articles

Burkitt lymphoma: click here to add to CAR-T?

Eliza A. Hawkes, Gareth P. Gregory

Blood (2025) 145 (23): 2678–2680.

https://doi.org/10.1182/blood.2025028549

Published: 2025

Journal Articles

Getting to the root of high-risk leukemias

Michael Poeschla, Vijay G. Sankaran

Blood (2025) 145 (23): 2673–2674.

https://doi.org/10.1182/blood.2025029069

Published: 2025

Journal Articles

MURANO’s final conclusions: what we’ve learned, what’s next?

Othman Al-Sawaf

Blood (2025) 145 (23): 2674–2676.

https://doi.org/10.1182/blood.2025028678

Published: 2025

Journal Articles

A great mitigator of non-ICANS neurotoxicities?

Jasia Mahdi

Blood (2025) 145 (23): 2682–2684.

https://doi.org/10.1182/blood.2025029233

Published: 2025

Journal Articles

The sweet business of VWF clearance

Renhao Li, Robert F. Sidonio, Jr.

Blood (2025) 145 (23): 2680–2681.

https://doi.org/10.1182/blood.2025029022

Published: 2025

Journal Articles

IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy

Blood (2025) 145 (23): 2746–2761.

https://doi.org/10.1182/blood.2024025755

Published: 2025

Includes: Supplemental data

Journal Articles

The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL

Blood (2025) 145 (23): 2733–2745.

https://doi.org/10.1182/blood.2024025525

Published: 2025

Includes: Supplemental data

Journal Articles

Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome

Blood (2025) 145 (23): 2685–2700.

https://doi.org/10.1182/blood.2024027270

Published: 2025

Includes: Supplemental data

Journal Articles

Enhanced α2-3–linked sialylation determines the extended half-life of CHO-rVWF

Ciara Byrne, Soracha Ward, Jamie O’Sullivan, Alain Chion, Patricia Lopes, Bogdan Baci, Caoimhe Dowd, Darragh Jordan, Ross Baker, Roger J. S. Preston, Marco Monopoli, Peter L. Turecek, Maximilianos Kotsias, Jack Cheeseman, Alan B. Moran, Richard A. Gardner, Daniel I. R. Spencer, Ferdows Atiq, James S. O’Donnell

Blood (2025) 145 (23): 2768–2773.

https://doi.org/10.1182/blood.2024027038

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of HLA alloimmunization in gene-modified autologous stem cell transplant for transfusion-dependent thalassemia

Nora M. Gibson, Eugene Khandros, Caitlin W. Elgarten, Elizabeth Worster, Dimitrios S. Monos, Alexis A. Thompson, Janet L. Kwiatkowski, Timothy S. Olson

Blood (2025) 145 (22): 2666–2670.

https://doi.org/10.1182/blood.2024027034

Published: 2025

Includes: Supplemental data

Journal Articles

Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT

Nicola Polverelli, Juan Carlos Hernández-Boluda, Francesco Onida, Carmelo Gurnari, Kavita Raj, Tomasz Czerw, Michelle Kenyon, Marie Robin, Katja Sockel, Annalisa Ruggeri, Isabel Sánchez-Ortega, Daniel A. Arber, Luca Arcaini, Fernando Barroso Duarte, Giorgia Battipaglia, Yves Chalandon, Fabio Ciceri, Nicholas C. P. Cross, Joanna Drozd-Sokolowska, Vaneuza Funke, Nico Gagelmann, Naseema Gangat, Jason Gotlib, Paola Guglielmelli, Claire Harrison, Gabriela Hobbs, Tania Jain, Joseph D. Khoury, Jean Jacques Kiladjian, Nicolaus Kröger, Luca Malcovati, Massimo Martino, Ruben Mesa, Attilio Orazi, Eric Padron, Francesca Palandri, Francesco Passamonti, Mrinal M. Patnaik, Naveen Pemmaraju, Deepti H. Radia, Andreas Reiter, Domenico Russo, Christof Scheid, Ayalew Tefferi, Alessandro M. Vannucchi, Daniel H. Wiseman, Ibrahim Yakoub-Agha, Donal P. McLornan

Blood (2025) 145 (22): 2561–2573.

https://doi.org/10.1182/blood.2024028000

Published: 2025

Includes: Supplemental data

Journal Articles

Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel cereblon E3 ligase modulators in myeloma

Yakinthi Chrisochoidou, Andrea Scarpino, Salomon Morales, Shannon Martin, Sarah Bird, Yigen Li, Brian Walker, John Caldwell, Yann-Vaï Le Bihan, Charlotte Pawlyn

Blood (2025) 145 (22): 2630–2644.

https://doi.org/10.1182/blood.2024025861

Published: 2025

Includes: Supplemental data

Journal Articles

Primary myelofibrosis involving lymph nodes with the same mutational profile in bone marrow

Yanna Ding, Kikkeri N. Naresh

Blood (2025) 145 (22): 2672.

https://doi.org/10.1182/blood.2025028556

Published: 2025

Journal Articles

SPI-ing on human B-cell development

Stuart G. Tangye

Blood (2025) 145 (22): 2535–2536.

https://doi.org/10.1182/blood.2025028405

Published: 2025

Journal Articles

Guidance on the interpretation of CRBN mutations in myeloma

K. Martin Kortüm, Hermann Einsele

Blood (2025) 145 (22): 2542.

https://doi.org/10.1182/blood.2024028272

Published: 2025

Journal Articles

HLA antibodies delay platelet recovery after gene therapy

Ashish O. Gupta, Akshay Sharma

Blood (2025) 145 (22): 2546–2547.

https://doi.org/10.1182/blood.2025028995

Published: 2025

Journal Articles

I+Ve got a question: how long should we treat relapsed CLL?

Moritz Fürstenau

Blood (2025) 145 (22): 2536–2538.

https://doi.org/10.1182/blood.2025028679

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Exploiting tumor-derived IL-10 activity in lymphoma therapy

The advent of multiomics in experimental transplantation

Classic Hodgkin lymphoma in the cerebellum: a rare site for a common disease

Burkitt lymphoma: click here to add to CAR-T?

Getting to the root of high-risk leukemias

MURANO’s final conclusions: what we’ve learned, what’s next?

A great mitigator of non-ICANS neurotoxicities?

The sweet business of VWF clearance

IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy

The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL

Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome

Enhanced α2-3–linked sialylation determines the extended half-life of CHO-rVWF

Impact of HLA alloimmunization in gene-modified autologous stem cell transplant for transfusion-dependent thalassemia

Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT

Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel cereblon E3 ligase modulators in myeloma

Primary myelofibrosis involving lymph nodes with the same mutational profile in bone marrow

SPI-ing on human B-cell development

Guidance on the interpretation of CRBN mutations in myeloma

HLA antibodies delay platelet recovery after gene therapy

I+Ve got a question: how long should we treat relapsed CLL?

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only